Daiwa Securities Group
JAZZ icon

Daiwa Securities Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Daiwa Securities Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-600
Closed -$273K – 1306
2024
Q2 		$273K Buy
+600
New +$66K ﹤0.01% 931

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Daiwa Securities Group's JAZZ Position: Q2 2026 in Review

Daiwa Securities Group increased its Jazz Pharmaceuticals (JAZZ) stake by 10% in Q2 2026, buying an estimated $329K and bringing the position to 16,500 shares worth $3.98M. The position accounts for 0.01% of the portfolio, ranked #563.

Daiwa Securities Group first reported a position in JAZZ in Q4 2014 and has held it in 47 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Daiwa Securities Group held 16,500 shares of Jazz Pharmaceuticals worth $3.98M as of Q2 2026.
  • Daiwa Securities Group bought 1,500 Jazz Pharmaceuticals shares in Q2 2026, an estimated $329K.
  • Jazz Pharmaceuticals made up 0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #563 holding.
  • Daiwa Securities Group first reported a position in Jazz Pharmaceuticals in Q4 2014 and has held it in 47 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.